Santen Pharmaceutical Co (SZD0) AI Stock Analysis

0 Followers

Santen Pharmaceutical Co

(Munich:SZD0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong ProfitabilitySanten’s strong gross, operating, and net margins indicate meaningful profitability in its specialty ophthalmology portfolio. This earnings structure can support reinvestment in research, product development, and commercialization while providing resilience across the next several quarters.

Negative Factors

Uneven Revenue MomentumSanten’s revenue trajectory is not consistently accelerating, with the reported growth measure negative and annual performance described as modest. Uneven top-line expansion can limit operating leverage and makes sustained earnings growth more dependent on margins and execution.

Santen Pharmaceutical Co (SZD0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 4.06B
Dividend Yield: 1.83%
Average Volume (3M): ―
Price to Earnings (P/E): 16.9
Beta (1Y): 0.18
Revenue Growth: -8.31%
EPS Growth: 17.13%
Country: Germany
Employees: 3,968
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - General

Santen Pharmaceutical Co Business Overview & Revenue Model

Company Description

Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan and international markets. The company maintains a s...

Santen Pharmaceutical Co Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:SZD0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LLY	81Outperform	$1.34T	46.73	83.65%	0.48%	45.51%	50.48%
NVS	72Outperform	$292.94B	30.72	24.24%	2.95%	1.64%	-28.72%
ABBV	71Outperform	$520.47B	50.60	-202.43%	2.35%	10.68%	338.08%
PFE	66Neutral	$164.33B	40.87	4.60%	5.95%	1.34%	-58.96%
MRK	64Neutral	$362.27B	149.25	5.29%	2.30%	5.21%	-86.88%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

DE:SZD0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:SZD0	Santen Pharmaceutical	11.30	2.61	29.96%
LLY	Eli Lilly And Company	1443.50	427.95	42.14%
MRK	Merck & Company	147.76	57.55	63.79%
NVS	Novartis AG	160.50	31.48	24.40%
PFE	Pfizer Inc	28.89	5.39	22.91%
ABBV	Abbvie	295.03	67.83	29.85%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Santen Pharmaceutical Co AI Stock Analysis